Amphastar Pharmaceuticals Inc

General ticker "AMPH" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $2.1B

Amphastar Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -9.5%.

Estimated limits based on current volatility of 2.3%: low 38.39$, high 40.20$

Factors to consider:

  • US accounted for 98.6% of revenue in the fiscal year ended 2023-12-31
  • Current price 16.1% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [46.64$, 69.46$]
  • 2024-12-30 to 2025-12-30 estimated range: [52.98$, 77.91$]

Financial Metrics affecting the AMPH estimates:

  • Positive: Non-GAAP EPS, $ of 3.30 > 2.29
  • Positive: Operating profit margin, % of 30.57 > 19.51
  • Positive: Interest expense per share, $ of 0.56 <= 0.74
  • Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term AMPH quotes

Long-term AMPH plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $437.77MM $498.99MM $644.39MM
Operating Expenses $367.88MM $391.49MM $447.41MM
Operating Income $69.89MM $107.50MM $196.99MM
Non-Operating Income $14.25MM $8.54MM $-25.63MM
Interest Expense $0.89MM $1.85MM $27.16MM
R&D Expense $60.93MM $74.77MM $73.74MM
Income(Loss) $84.14MM $116.04MM $171.36MM
Taxes $20.63MM $23.48MM $31.83MM
Other Income(Loss) $-0.21MM $-1.18MM $-1.98MM
Profit(Loss) $63.30MM $91.39MM $137.54MM
Stockholders Equity $445.52MM $528.66MM $639.42MM
Inventory $92.81MM $103.58MM $105.83MM
Assets $671.53MM $741.99MM $1,512.91MM
Operating Cash Flow $97.99MM $89.18MM $183.50MM
Capital expenditure $27.46MM $24.03MM $38.17MM
Investing Cash Flow $-28.67MM $-32.78MM $-649.12MM
Financing Cash Flow $-37.02MM $-26.44MM $454.09MM
Earnings Per Share* $1.30 $1.88 $2.85

* EPS are Split Adjusted, recent splits may be reflected with a delay.